In India, it is the pharma sector that fits the bill. For a simple reason. While the Trump regime will make noises about tariffs on Indian pharma imports, the reality is that, given the poor state of ...

Drugmaker Natco Pharma on Tuesday said it intends to launch its generic version of spinal muscular atrophy drug Risdiplam only after and subject to successful clarity from the Appellate Bench of ...

Joining GlaxoSmithKline's board in 2017, her Dana-Farber biography mentions her directorships for the pharma as well as Waters Corporation, which makes laboratory equipment. "At Dana-Farber, we have ...

Natco Pharma on Tuesday shared a legal update on the legal proceedings on the Risdiplam compound (used for treating spinal muscular atrophy) launch in India. "The company has received numerous ...

Natco Pharma today updates on the legal proceedings on Risdiplam launch in India. The Company has received numerous enquiries from investors and patients about the launch, availability and pricing of ...

Natco Pharma on April 8 said that the launch of its generic version of Roche Pharma's patented drug, Risdiplam, is contingent upon the successful outcome in a patent infringement case.

The company is trading at a discount of 50 percent from its all-time high of Rs 748.10 per share. NATCO Pharma Limited is a global pharmaceutical company that is engaged in the development, ...

Natco Pharma has decided to price Risdiplam, indicated for the treatment of rare genetic disorder Spinal Muscular Atrophy (SMA), at₹15,900. In an update on the legal proceedings on the ...

FRANKFURT/LONDON: European pharma companies warned the European Commission president at a meeting on Tuesday that U.S. tariffs would expedite the industry’s shift away from Europe and toward the ...

Price Band changes from 10% to 20%: Anant Raj, APAR Industries, Adani Wilmar, Bharat Wire Ropes, Concord Enviro Systems, Cochin Shipyard, Dynemic Products, Excel Industries, Hind Rectifiers, Inox Wind ...